FGF21 and metabolic syndrome: The primary aim of this investigation is to assess the concentrations of fibroblast growth factor 21 (FGF-21), sortilin, meteorin-like protein (Metrnl), and nesfatin-1 in individuals with obesity, regardless of the presence of carbohydrate metabolism abnormalities, within the context of metabolic syndrome.